Squarepoint Ops LLC Merus N.V. Transaction History

Squarepoint Ops LLC

$96.1 Billion
Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Merus N.V. stock. As of the latest transaction made, Squarepoint Ops LLC holds 19,608 shares of MRUS stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,608

Holding current value

$1.88 Million

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$52.33 - $94.15 $1.03 Million - $1.85 Million	19,608 New	19,608 $1.85 Million
Q1 2025 Aug 27, 2025	BUY	$39.01 - $49.16 $648,190 - $816,842	16,616 New	16,616 $699,000
Q1 2025 May 15, 2025	SELL	$39.01 - $49.16 $110,164 - $138,827	-2,824 Reduced 14.53%	16,616 $699,000
Q4 2024 Feb 14, 2025	BUY	$41.45 - $54.5 $805,788 - $1.06 Million	19,440 New	19,440 $817,000
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $322,793 - $553,359	-28,465 Closed	0 $0

Q4 2019 Feb 14, 2020	BUY	$14.08 - $18.5 $400,787 - $526,602	28,465 New	28,465 $401,000
Q2 2019 Aug 14, 2019	SELL	$12.93 - $16.83 $144,816 - $188,495	-11,200 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.09 - $15.83 $6,654 - $9,498	-600 Reduced 5.08%	11,200 $165,000
Q4 2018 Feb 14, 2019	BUY	$11.46 - $20.81 $12,606 - $22,891	1,100 Added 10.28%	11,800 $165,000
Q3 2018 Nov 14, 2018	BUY	$18.47 - $26.39 $197,629 - $282,373	10,700 New	10,700 $211,000

Others Institutions Holding MRUS

# of Institutions

287

Shares Held

64.1M

Call Options Held

1.65M

Put Options Held

758K

Paradigm Biocapital Advisors LP New York, NY

4.37M
Shares

$420 Million
13.26% of portfolio
Avoro Capital Advisors LLC New York, NY

3.54M
Shares

$340 Million
4.56% of portfolio
Commodore Capital LP New York, NY

3.53M
Shares

$338 Million
21.18% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

3.05M
Shares

$292 Million
5.34% of portfolio
Hbk Investments L P Dallas, TX

2.85M
Shares

$273 Million
3.71% of portfolio

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $4.4B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account